These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 23378769

  • 1. Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment.
    Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W.
    Vasc Health Risk Manag; 2013; 9():21-8. PubMed ID: 23378769
    [Abstract] [Full Text] [Related]

  • 2. Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea.
    Garber AJ, Foley JE, Banerji MA, Ebeling P, Gudbjörnsdottir S, Camisasca RP, Couturier A, Baron MA.
    Diabetes Obes Metab; 2008 Nov; 10(11):1047-56. PubMed ID: 18284434
    [Abstract] [Full Text] [Related]

  • 3. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S.
    Cochrane Database Syst Rev; 2017 Feb 27; 2(2):CD009966. PubMed ID: 28238223
    [Abstract] [Full Text] [Related]

  • 4. Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.
    Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S.
    Diabetologia; 2007 Jun 27; 50(6):1148-55. PubMed ID: 17387446
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.
    Hassanein M, Abdallah K, Schweizer A.
    Vasc Health Risk Manag; 2014 Jun 27; 10():319-26. PubMed ID: 24920915
    [Abstract] [Full Text] [Related]

  • 6. A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.
    Haidinger M, Werzowa J, Voigt HC, Pleiner J, Stemer G, Hecking M, Döller D, Hörl WH, Weichhart T, Säemann MD.
    Trials; 2010 Oct 06; 11():91. PubMed ID: 20925938
    [Abstract] [Full Text] [Related]

  • 7. Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus.
    Yang W, Xing X, Lv X, Li Y, Ma J, Yuan G, Sun F, Wang W, Woloschak M, Lukashevich V, Kozlovski P, Kothny W, all investigators.
    J Diabetes; 2015 Mar 06; 7(2):174-81. PubMed ID: 24823599
    [Abstract] [Full Text] [Related]

  • 8. Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.
    Garber AJ, Schweizer A, Baron MA, Rochotte E, Dejager S.
    Diabetes Obes Metab; 2007 Mar 06; 9(2):166-74. PubMed ID: 17300592
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea.
    Lukashevich V, Del Prato S, Araga M, Kothny W.
    Diabetes Obes Metab; 2014 May 06; 16(5):403-9. PubMed ID: 24199686
    [Abstract] [Full Text] [Related]

  • 10. Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
    Farngren J, Persson M, Schweizer A, Foley JE, Ahrén B.
    Diabetes Obes Metab; 2014 Sep 06; 16(9):812-8. PubMed ID: 24612221
    [Abstract] [Full Text] [Related]

  • 11. Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus.
    Ning G, Wang W, Li L, Ma J, Lv X, Yang M, Wang W, Woloschak M, Lukashevich V, Kothny W.
    J Diabetes; 2016 May 06; 8(3):345-53. PubMed ID: 25929739
    [Abstract] [Full Text] [Related]

  • 12. Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.
    Bolli G, Dotta F, Colin L, Minic B, Goodman M.
    Diabetes Obes Metab; 2009 Jun 06; 11(6):589-95. PubMed ID: 19515179
    [Abstract] [Full Text] [Related]

  • 13. A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study.
    Filozof C, Gautier JF.
    Diabet Med; 2010 Mar 06; 27(3):318-26. PubMed ID: 20536495
    [Abstract] [Full Text] [Related]

  • 14. Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin.
    Schweizer A, Foley JE, Kothny W, Ahrén B.
    Vasc Health Risk Manag; 2013 Mar 06; 9():57-64. PubMed ID: 23431062
    [Abstract] [Full Text] [Related]

  • 15. Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.
    Mikhail N.
    Expert Opin Investig Drugs; 2008 Jun 06; 17(6):845-53. PubMed ID: 18491986
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus.
    Pan C, Xing X, Han P, Zheng S, Ma J, Liu J, Lv X, Lu J, Bader G, Institution Investigators.
    Diabetes Obes Metab; 2012 Aug 06; 14(8):737-44. PubMed ID: 22369287
    [Abstract] [Full Text] [Related]

  • 17. Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
    Pratley RE, Schweizer A, Rosenstock J, Foley JE, Banerji MA, Pi-Sunyer FX, Mills D, Dejager S.
    Diabetes Obes Metab; 2008 Sep 06; 10(10):931-8. PubMed ID: 18093207
    [Abstract] [Full Text] [Related]

  • 18. Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia.
    Scherbaum WA, Schweizer A, Mari A, Nilsson PM, Lalanne G, Wang Y, Dunning BE, Foley JE.
    Diabetes Obes Metab; 2008 Nov 06; 10(11):1114-24. PubMed ID: 18355325
    [Abstract] [Full Text] [Related]

  • 19. Vildagliptin: a review of its use in type 2 diabetes mellitus.
    Keating GM.
    Drugs; 2010 Nov 12; 70(16):2089-112. PubMed ID: 20964454
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus.
    Kikuchi M, Haneda M, Koya D, Tobe K, Onishi Y, Couturier A, Mimori N, Inaba Y, Goodman M.
    Diabetes Res Clin Pract; 2010 Sep 12; 89(3):216-23. PubMed ID: 20537746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.